LKT Labs

Biochemicals for Life Science Research

PF-3845

PF-3845

Product ID P200000
Cas No. 1196109-52-0
Purity ≥98%
Product Unit SizeCostQuantityStock
5 mg $136.10 In stock
25 mg $500.90 In stock
100 mg $1,402.30 In stock
Bulk Quote

Quicklinks

Description

PF-3845 is an inhibitor of fatty acid amide hydrolase (FAAH). PF-3845 shows anti-allodynic effects in mice stimulated with LPS. It generates this effect without displaying any cannabinolic effects, making it a target for inflammatory pain management. When PF-3845 is used in tandem with the monoacyglycerol lipase (MAGL) inhibitor JZL184, it lessens withdrawal effects from opioid-dependent mice and produces anti-nociceptive effects without cannabimimetic side effects. Studies of PF-3845 treatment for traumatic brain injury in mice showed that PF-3845 lessened impairments found in control mice.

Product Info

Cas No.

1196109-52-0
Purity

≥98%
Formula

C24H23F3N4O2
Formula Wt.

456.47
Chemical Name

N-3-Pyridinyl-4-[[3-[[5-(trifluoromethyl)-2-pyridinyl]oxy]phenyl]methyl]-1-piperidinecarboxamide hydrate
IUPAC Name

N-pyridin-3-yl-4-[[3-[5-(trifluoromethyl)pyridin-2-yl]oxyphenyl]methyl]piperidine-1-carboxamide
Synonym

PF3845
Solubility

DMSO (>45 mg/mL)
Appearance

White to off-white powder

Shipping and Storage

Store Temp

-20°C
Ship Temp

Ambient

Downloads

MSDS

P200000 MSDS PDF
Info Sheet

P200000 Info Sheet PDF

References

Booker L, Kinsey SG, Abdullah RA et al. The fatty acid hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice. Br J Pharmacol. 2012 Apr;165(8):2485-96. PMID: 21506952.

Ramesh D, Gamage TF, Vanuytsel T et al. Dual Inhibition of endocannabinoid catabolic enzymes produces enhanced antiwithdrawal effects in morphine-dependent mice. Neuropsychopharmacology. 2013 May;38(6):1039-49. PMID: 23303065

Tchantchou F, Tucker LB, Fu AH, et al. The fatty acid amide hydrolase inhibitor PF-3845 promotes neuronal survival, attenuates inflammation and improves functional recovery in mice with traumatic brain injury. Neuropharmacology. 2014 Oct;85:427-39. PMID: 24937045

Ghosh S, Kinsey SG Liu QS et al. Full Fatty ACid Amide Hydrolase Inhibition Combined with Partial Monoacylglycerol Lipase Inhibition: Augmented and Sustained Antinociceptive Effects with Reduced Cannabimemetic Side Effects in Mice. J Pharmacol Exp Ther. 2015 Aug;354(2):111-20. PMID25998048.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • R3013

    Recombinant TpN 44.50 protein

    Recombinant protein containing Treponema pallid...

    ≥95%
  • G5752

    Gonadorelin Acetate

    Synthetic peptide, GnRH derivative; GnRH agonist.
    ≥95%
  • S8010

    [Nle11]-Substance P

    Endogenous tachykinin peptide, involved in infl...

    ≥95%
  • H9615

    17α-Hydroxyprogesterone Caproate

    Synthetic steroid hormone; ER antagonist.

    ≥98%
  • L1817

    Leflunomide

    AhR agonist, dihydroorotate dehydrogenase inhib...

    ≥98%
  • A5219

    Anethole Trithione

    Oltipraz analog, salivary gland secretion enhan...

    ≥98%
  • S3476

    Sitagliptin Phosphate Monohydrate

    DPP4 inhibitor.

    ≥98%
  • R3010

    Recombinant Tp-chimeric protein

    Recombinant chimeric protein containing Trepone...

    ≥95%
  • C5662

    Copper Bis-3,5-diisopropylsalicylate

    Antioxidant.

    ≥97%
  • K1776

    Ketotifen Fumarate

    H1 histamine and LT antagonist, PDE inhibitor.<...

    ≥98%
  • V182705

    Verubecestat

    BACE1 inhibitor

    ≥98%
  • I6068

    Ipriflavone

    Synthetic isoflavone.

    ≥98%
  • U6901

    Uracil

    Endogenous pyrimidine base required for product...

    ≥98%
  • T1979

    Tetrahydrocoptisine

    Alkaloid compound originally found in Corydalis...

    ≥98%
  • B5609

    Boc-GRR-AMC

    Peptide, protease substrate.

    ≥98%
  • S6134

    Spinorphin, bovine

    Endogenous heptapeptide; P2X3 and N-formylpepti...

    ≥95%
  • I0801

    IC261

    Casein kinase 1 inhibitor.

    ≥98%
  • W7201

    WS6

    Islet α/β cell proliferation stimulator.

    ≥98%
  • R3312

    Ridaifen A Dihydrochloride

    Tamoxifen derivative; potential proteasome inhi...

    ≥98%
  • A4849

    Amyloid-β (25-35)

    Endogenous APP peptide cleavage product, primar...

    ≥95%